SynthesisPloS one2022

Efficacy and harms of tocilizumab for the treatment of COVID-19 patients: A systematic review and meta-analysis.

Alejandro Piscoya et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.